Building AI Agents for Longevity
Join us to learn about the applications of agentic AI in longevity. The session will bring together thought leaders from venture capital, clinical practice, and AI/agent systems to discuss open problems and unmet needs in extending human healthspan. The aim is to provide participants with a scientifically grounded view of where major breakthroughs are still needed, spanning drug discovery, digital biomarkers, data-driven interventions, and translational longevity research, and to inspire new ideas at the intersection of biology, technology, and healthcare.
Learn from innovators who are already funding, operating, and building AI systems for longevity:
Joachim Rautter - Co-founder and Managing Director, Peppermint Venture Partners
Jan K. Hennigs - Founding Head of Medicine & Science, YEARS
Emre Ulgac - AI Engineer, Bio Protocol
Moderated by Nico Alavi - Co-managing Director, Nucleate Germany
They will explore:
The Opportunity Spaces: Where agentic AI creates real value in biomedicine versus where it's just hype
The Business Models: Which agent architectures become fundable companies versus weekend projects
The Build Targets: Specific challenges worth solving if you're new to longevity AI
This is your chance to meet builders, form teams, and move from idea to prototype faster during the Longevity Agents X Berlin hackathon
Open to non-participants too, but limited to 70 people - register now to secure your spot.
Drinks and refreshments are provided.
ORGANIZERS
Longevity Hacks - Venture builder running global innovation sprints to build AI for longevity startups
Nucleate Germany - Nonprofit organisation led by academic trainees dedicated to empowering the next generation of biotech leaders
Molecule AG - Decentralised biotech protocol porting intellectual property into web3 and launching biotech DAOs